Khalid Saad Alharbi (Khalid S Alharbi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

International journal of nanomedicine

Biotechnology and applied biochemistry

Drug design, development and therapy

Brazilian journal of biology = Revista brasleira de biologia

Al-Jouf University College of Pharmacy

Strathclyde Institute of Pharmacy and Biomedical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Al-Jouf University College of Pharmacy

Saudi Arabia

Assistant Professor :: College of Pharmacy, Department of Pharmacology

Education History

Strathclyde Institute of Pharmacy and Biomedical Sciences Oct 01 2012 - Nov 10 2016

United Kingdom

PHD

Publications

Arafa Musa, Saleh K Ihmaid, David L Hughes, Musa A Said, Hamada S Abulkhair, Ahmed H El-Ghorab, Mohamed Abdelwahab Abdelgawad, Khaled Shalaby, Mohamed E Shaker, Khalid Saad Alharbi, Nasser Hadal Alotaibi, Deborah L Kays, Laurence J Taylor, Della Grace Thomas Parambi, Sami I Alzarea, Ahmed Ali Al-Karmalawy, Hany E A Ahmed, Ahmed M El-Agrody
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations. Journal of biomolecular structure & dynamics (2023)
Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Omar Awad Alsaidan, Faisal K Alkholifi, Khalid Saad Alharbi, Ehab M Mostafa, Abdullah Salah Alanazi, Sadaf Jamal Gilani, Arafa Musa, Sultan M Alshehri, Alenazy Rawaf, Ali H Alquraini
Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment. Pharmaceutics 13 (12) (2021)
Khalid Saad Alharbi
Anticonvulsant effects of desvenlafaxine on modulating brain monoamine and oxidative stress in mice. Brazilian journal of biology = Revista brasleira de biologia 83 (2021)
Shumin Li, Zhongkai Xu, Majed Alrobaian, Obaid Afzal, Imran Kazmi, Waleed Hassan Almalki, Abdulmalik Saleh Alfawaz Altamimi, Fahad A Al-Abbasi, Khalid Saad Alharbi, Waleed M Altowayan, Tanuja Singh, Md Habban Akther, Manish Gupta, Mahfoozur Rahman, Sarwar Beg
EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma. Biotechnology and applied biochemistry (2021)
Nabil K Alruwaili, Ameeduzzafar Zafar, Syed Sarim Imam, Khalid Saad Alharbi, Nasser Hadal Alotaibi, Sultan M Alshehri, Nabil Abdulhafiz Alhakamy, Abdulaziz Ibrahim Alzarea, Muhammad Afzal, Mohammed Elmowafy
Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment. International journal of nanomedicine 15 (2020)
Mohammad M Al-Sanea, Lizaveta Gotina, Mamdouh Fa Mohamed, Della Grace Thomas Parambi, Hesham A M Gomaa, Bijo Mathew, Bahaa G M Youssif, Khalid Saad Alharbi, Zainab M Elsayed, Mohamed Abdelwahab Abdelgawad, Wagdy M Eldehna
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety. Drug design, development and therapy 14 (2020)

Khalid Saad Alharbi.css-eqlu8i{font-size:small;padding-left:4px;} (Khalid S Alharbi)

Publication Activity (10 Years)

Top Topics

Top Venues

Khalid Saad Alharbi (Khalid S Alharbi)